Incidence of intravenous (IV) hydration post anthracycline-cyclophosphamide (AC) chemotherapy in breast cancer patients

被引:0
|
作者
Navari, Rudolph M. [1 ,2 ]
Mosier, Michael C. [3 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] World Hlth Org, Canc Care Program, Birmingham, AL USA
[3] EMB Stat Solut LLC, Overland Pk, KS USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS9-61
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Antiemetic efficacy of intravenous (IV) NEPA in patients with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy.
    Schwartzberg, Lee S.
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [2] Safety of intravenous (IV) NEPA and oral NEPA for prevention of CINV in patients (pts) with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy (CT).
    Schwartzberg, Lee S.
    Voisin, Daniel
    Rizzi, Giada
    Patel, Kamal
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC)-based chemotherapy
    Schnadig, Ian D.
    Modiano, Manuel R.
    Poma, Allen
    Arora, Sujata
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC) based chemotherapy.
    Powers, Daniel
    Schnadig, Ian D.
    Modiano, Manuel R.
    Arora, Sujata
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [5] EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY
    Rugo, Hope
    Aapro, Matti
    Rossi, Giorgia
    Rizzi, Giada
    BREAST, 2015, 24 : S60 - S60
  • [6] Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer
    Saito, Yoshitaka
    Takekuma, Yoh
    Takahashi, Masato
    Oshino, Tomohiro
    Sugawara, Mitsuru
    SUPPORTIVE CARE IN CANCER, 2024, 32 (08)
  • [7] Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer
    Nawa-Nishigaki, Minako
    Kobayashi, Ryo
    Suzuki, Akio
    Hirose, Chiemi
    Matsuoka, Rie
    Mori, Ryutaro
    Futamura, Manabu
    Sugiyama, Tadashi
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    ANTICANCER RESEARCH, 2018, 38 (02) : 877 - 884
  • [8] Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer
    Veronese, Pedro
    Hachul, Denise Tessariol
    Scanavacca, Mauricio Ibrahim
    Hajjar, Ludhmila Abrahao
    Wu, Tan Chen
    Sacilotto, Luciana
    Veronese, Carolina
    da Costa Darrieux, Francisco Carlos
    PLOS ONE, 2018, 13 (05):
  • [9] Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
    Schwartzberg, Lee
    Navari, Rudolph
    Clark-Snow, Rebecca
    Arkania, Ekaterine
    Radyukova, Irena
    Patel, Kamal
    Voisin, Daniel
    Rizzi, Giada
    Wickham, Rita
    Gralla, Richard J.
    Aapro, Matti
    Roeland, Eric
    ONCOLOGIST, 2020, 25 (03): : E589 - E597
  • [10] Hepatotoxicity of anthracycline chemotherapy in patients with breast cancer
    Guskova, Nailya
    Kit, Oleg I.
    Vladimirova, Liubov Yu
    Tikhanovskaya, Natalya Mikhailovna
    Sycheva, Elena A.
    Nozdricheva, Anastasia
    Abakumova, Svetlana V.
    Abramova, Natalya A.
    Storozhakova, Anna E.
    Popova, Irina L.
    Ryadinskaya, Ludmila A.
    Lyanova, Aza A.
    Novoselova, Kristina A.
    Lisunova, Zinaida P.
    Avanesova, Kristina
    Zekhtser, Ineya I.
    Belgova, Svetlana V.
    Zakharchenko, Viktoria
    Tselishcheva, Irina V.
    Torpudzhyan, Izabella
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)